Everence Capital Management’s Medicines Co MDCO Stock Holding History

Everence Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,540	Closed	-$810K	–	704
2019 Q4	$810K	Hold	9,540	–	–	0.12%	180
2019 Q3	$477K	Hold	9,540	–	–	0.08%	276
2019 Q2	$348K	Hold	9,540	–	–	0.06%	378
2019 Q1	$267K	Buy	+9,540	New	+$225K	0.05%	452
2017 Q2	–	Sell	-4,760	Closed	-$233K	–	387
2017 Q1	$233K	Buy	+4,760	New	+$217K	0.06%	312

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Everence Capital Management's MDCO Position: Q1 2020 in Review

Everence Capital Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 9,540 shares — an estimated $810K sold.

Everence Capital Management first reported a position in MDCO in Q1 2017 and held it in 5 quarters. The position peaked at $810K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Everence Capital Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Everence Capital Management sold 9,540 Medicines Co shares in Q1 2020, an estimated $810K.
Everence Capital Management first reported a position in Medicines Co in Q1 2017 and held it in 5 quarters.
Everence Capital Management's Medicines Co position peaked at $810K in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Everence Capital Management's 13F filing for Q1 2020, filed 23 Apr 2020.